ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "Autoinflammatory diseases"

  • Abstract Number: 1062 • ACR Convergence 2024

    Assessing Musculoskeletal Symptom Burden in a Cohort of Patients with Hidradenitis Suppurativa Using the IDEOM MSK-Q

    Gretchen Ball1, Hassan Hamade2, Sarah Romanelli2, Zachary Levy2, Lourdes Perez Chada3, Joseph Merola4 and Alice Gottlieb5, 1Albert Einstein College of Medicine, Ridgefield, CT, 2Icahn School of Medicine at Mount Sinai, New York, NY, 3Brigham and Women’s Hospital, Harvard Medical School, Boston, MA, 4UT Southwestern Medical Center, Newton, MA, 5Icahn School of Medicine at Mount Sinai, Department of Dermatology, Seattle, WA

    Background/Purpose: Hidradenitis suppurativa (HS) has been associated with inflammatory joint diseases such as psoriatic arthritis and ankylosing spondylitis.  Despite this correlation, dermatologists do not routinely…
  • Abstract Number: 1778 • ACR Convergence 2024

    A Novel Variant in IRAK2 Results in Immune Dysregulation in Systemic Juvenile Idiopathic Arthritis (sJIA)

    Mariana Correia Marques1, Brooke Boyd2, Alana Platukus3, Elizabeth Schmitz2, Hiroto Nakano2, Faiza Naz4, Anthony Cruz1, Stefania Dell'Orso4, Zuoming deng4 and Michael Ombrello5, 1National Institutes of Health, Bethesda, MD, 2Translational Genetics and Genomics Section, National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, Bethesda, MD, Bethesda, MD, 31Translational Genetics and Genomics Section, National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, Bethesda, MD, Bethesda, MD, 4National Institutes of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), National Institutes of Health (NIH), Bethesda, MD, Bethesda, MD, 5National Institute of Arthritis and Musculoskeletal and Skin Diseases, Bethesda, MD

    Background/Purpose: Lung disease (LD) is poorly understood complication of Still’s disease with high fatality. HLA-DRB1*15 is a strong risk factor for the development of this…
  • Abstract Number: 2054 • ACR Convergence 2024

    Phenotypical Differences in VEXAS Syndrome, Where Are We a Year Later? Results from a National Cohort Focused on Rheumatological Patients

    Paula García Escudero1, Marta López I Gómez2, Berta Magallanes López3, Diego Dios Santos4, Francisco Javier Toyos Sáenz de Miera5, Alicia García Dorta6, José Ángel Hernández Beriain7, Íñigo Rúa-Figueroa8, cristiana sieiro santos9, Elvira Díez Álvarez10, Marta Ibáñez Martínez11, Beatriz Frade-Sosa12, Judit Font Urgelles13, Meritxell Sallés Lizarzaburu14, Elena Riera Alonso15, Ernesto Trallero Araguás16, Eugenia Enríquez Merayo17, Maria Rodriguez-Laguna18, irene monjo19, Carolina Merino20, Paloma Vela-Casasempere21, Ignacio Vázquez Gómez22, Jose Alberto Miranda Filloy23, Rafael Benito Melero-Gonzalez24, Clara Garcia Belando25, Giuliano Boselli26, Alina Lucica Boteanu27, Dolly Viviana Fiallo Suárez28, Cristina Corrales Selaya29, ALBERTO MARIANO RUIZ ROMAN30 and Jaime Calvo-Alén31, 1Hospital Universitario Araba, Vitoria, 2Hospital Universitario Alava, Vitoria, Pais Vasco, Spain, 3Hospital de la Santa Creu i Sant Pau, Barcelona, 4C. H. U. A Coruña, C. H. U. A Coruña, 5H. U. Virgen Macarena, H. U. Virgen Macarena, 6Rheumatologist, La Laguna, Spain, 7Rheumatology Department. Hospital Universitario Insular de Gran Canaria, Las Palmas de Gran C, Spain, 8Department of Rheumatology, Hospital Universitario Doctor Negrín, Las Palmas de Gran Canaria, Las Palmas GC, Spain, 9Rheumatology Department, Complejo Asistencial Universitario de León, León, Spain, Leon, Spain, 10Complejo Asistencial Universitario de León, León, Spain, 11Hospital Clínico Universitario de Salamanca, Salamanca, Spain, 12Hospital Clinic de Barcelona, Barcelona, Spain, 13Hospital Universitari Germans Trias i Pujol, Badalona, Spain, 14Althaia Xarxa Assistencial Universitària Manresa, Manresa, Catalonia, Spain, 15Mutua de Terrasa, Barcelona, 16Hospital Vall D'Hebron, Barcelona, Spain, 17Hospital 12 de Octubre, Madrid, 18Resident in Rheumatology, Madrid, Spain, 19University Hospital La Paz, Madrid, Spain, 20Hospital Universitario Puerta de Hierro Majadahonda., Majadahonda (Madrid), Spain, 21Hospital General Universitario Alicante, Alicante, Spain, 22H. U. Dr. Peset, Valencia, 23C. H. U. Lucus Augusti, Lugo, Spain, 24CHU Ourense, O Carballino, Spain, 25H. C. U. Virgen de la Arrixaca, Murcia, 26hospital miguel servet, zaragoza, Aragon, Spain, 27H.U. Ramón y Cajal, Madrid, Spain, 28H. U. de Gran Canaria. Dr. Negrin, H. U. de Gran Canaria, 29Rheumatology, Marques de Valdecilla University Hospital. IDIVAL, Santander, Cantabria, Spain, 30Hospital Universitario Juan Ramón Jiménez, Huelva, Spain, 31Department of Rheumatology, Hospital Araba, Vitoria, Pais Vasco, Spain

    Background/Purpose: VEXAS syndrome is an autoinflammatory disorder caused by a mutation in the UBA1 gene, which leads to a heterogeneous clinical presentation and progressive bone…
  • Abstract Number: PP09 • ACR Convergence 2024

    Finding the Balance: Regaining My Strength While Living with Sjögren’s & POTS

    Robert Fearon, Sjögren's Foundation, Reston, VA

    Background/Purpose: Like many suffering from autoimmune diseases, my diagnosis was not straightforward and took nearly 13 years to get answers. I first started experiencing an…
  • Abstract Number: 0072 • ACR Convergence 2024

    The Association Between Activation of Inflammasome and HLA-B27 in Dendritic Cells of Patients with Axial Spondyloarthritis

    Jina Yeo1, Min-Gang Kim2, Hye Eun Lee3, Yeonsoo Yang2, Mi Ryoung Seo1, Hyo-Jin Choi1, Eun Young Lee4, Dae Ho Lee3 and Han Joo Baek5, 1Division of Rheumatology, Department of Internal Medicine, Gil Medical Center, Gachon University College of Medicine, Incheon, Republic of Korea, 2Department of Biomedical Sciences, Seoul National University College of Medicine, Seoul, Republic of Korea, 3Division of Endocrinology, Department of Internal Medicine, Gil Medical Center, Gachon University College of Medicine, Incheon, Republic of Korea, 43Division of Rheumatology, Department of Internal Medicine, Seoul National University Hospital, Seoul, Republic of Korea, 5Division of Rheumatology, Department of Internal Medicine, Gil Medical Center, Gachon University College of Medicine, Inchon, South Africa

    Background/Purpose: Axial spondyloarthritis (axSpA) exhibits a predominant involvement of the innate immune system, marked by abnormal functions of innate immune cell such as dendritic cells…
  • Abstract Number: 0414 • ACR Convergence 2024

    Relationship Between Culture Negative Infectious Osteomyelitis and Chronic Nonbacterial Osteomyelitis

    Andrew Grim1, Yongdong (Dan) Zhao2, Christine Wang1, Erin Janssen3, Jessica Turnier4, Anastasia Hyrhorczuk1 and Nadine Saad1, 1University of Michigan, Ann Arbor, MI, 2University of Washington, Redmond, WA, 3CS Mott Children's Hospital, Ann Arbor, MI, 4University of Michigan, Saline, MI

    Background/Purpose: Chronic nonbacterial osteomyelitis (CNO) is a rare autoinflammatory bone disorder. Some patients with CNO may present acutely and be misdiagnosed as infectious osteomyelitis (IO).…
  • Abstract Number: 1112 • ACR Convergence 2024

    Pleuroparenchymal Fibroelastosis Associated with Connective Tissue Diseases (PPFE-CTD)

    Maximiliano Diaz Menindez1, Alejandro Diaz Arumir Vergara2, Vivian Shing2, carolyn mead harvey3, Ana Zamora Martinez2 and Vivek Nagaraja4, 1Mayo Clinic School of Graduate Medical Education, Phoenix, AZ, 2Mayo Clinic, Phoenix, 3Mayo Clinic Florida, Jacksonville, FL, 4Mayo Clinic Arizona, Scottsdale, AZ

    Background/Purpose: Pleuroparenchymal Fibroelastosis (PPFE) is a rare idiopathic interstitial pneumonia characterized by fibrosis of the visceral pleura and subpleural parenchyma, predominantly affecting the upper lobes.…
  • Abstract Number: 1788 • ACR Convergence 2024

    Memory B Cell Activation and Dysregulation in Systemic Lupus Erythematosus

    Shady Younis1, Salvinaz Moutusy2, Shaghayegh Jahanbani2, Xiaohao Wu2, Marlayna Harris2, Mahesh Pandit3, Laura van Dam4, orr Sharpe5, Paul Utz1 and William Robinson6, 1Stanford University, Stanford, CA, 2Stanford University School of Medicine, Stanford, 3Stanford University School of Medicine, Stanofrd, 4Stanford, Palo Alto, CA, 5Department of Immunology and Rheumatology, Stanford University, Stanford, CA, 6Division of Immunology and Rheumatology, Stanford University, and VA Palo Alto Health Care System, Stanford, CA

    Background/Purpose: B cell dysregulation and production of autoantibodies against autoantigens are hallmarks of Systemic lupus erythematosus (SLE). In healthy adults (HC), B cells with autoreactive…
  • Abstract Number: 2152 • ACR Convergence 2024

    Factors Associated with Health-related Quality of Life in Adults with SAPHO and Chronic Nonbacterial Osteomyelitis – a Cross Sectional Analysis from the SAPHO-CNO Study

    Aleksander Lenert1, Helena Abodeely1, Karmela Kim Chan2, Sandy Hong3, Arundathi Jayatilleke4, Courtney Kremer5, Emma Leisinger1, Petar Lenert6, Melissa Oliver7, T. Shawn Sato8, Melanie Smith2, Thomason Jenna9, Yongdong (Dan) Zhao10, Jonathan Templin1, Robyn Domsic11, Mary Vaughan-Sarrazin1, Daniel Solomon12 and Polly Ferguson13, 1University of Iowa, Iowa City, IA, 2Hospital For Special Surgery, New York, NY, 3University of Iowa Stead Family Children's Hospital, Iowa City, IA, 4Temple University, Philadelphia, PA, 5University of Iowa Stead Family Children's Hospital, Solon, Iowa, IA, 6University of Iowa Hospitals and Clinics, Iowa City, IA, 7Indiana University, Indianapolis, IN, 8University of Iowa, Iowa City, 9University of Washington, Division of Rheumatology, Seattle, WA, 10University of Washington, Redmond, WA, 11Division of Rheumatology and Clinical Immunology, University of Pittsburgh School of Medicine, Pittsburgh, PA, 12Brigham and Women's Hospital, Newton, MA, 13University of Iowa Carver College of Medicine, Iowa City, IA

    Background/Purpose: Health-related quality of life (HRQOL) is decreased in individuals with chronic rheumatic diseases (CRD) yet remains undefined in adults with SAPHO syndrome and chronic…
  • Abstract Number: PP10 • ACR Convergence 2024

    Walking Away from Arthritis Pain: Exercise Helped Me Manage Sarcoidosis and Osteoarthritis Physically and Emotionally

    Bridget Kelly, Hospital for Special Surgery, Rockville Centre, NY

    Background/Purpose: In 2004, we moved to a new home with 2 small children, when I started experiencing terrible joint pain. For 2 years I was…
  • Abstract Number: 0081 • ACR Convergence 2024

    The Axial Spondyloarthritis Risk Variant CARD9 S12N Enhances Neutrophil-mediated Th Responses

    Hillary Struthers1, Kofi Asare-Konadu2, Emily Vance1 and Ruth Napier3, 1Oregon Health & Science University, Portland, OR, 2Department of Molecular Microbiology and Immunology, Oregon Health & Science University, Portland, OR, 3Department of Molecular Microbiology and Immunology and Division of Arthritis and Rheumatic Disease, Oregon Health & Science University, VA Portland Health Care System, Portland, OR

    Background/Purpose: Axial spondyloarthritis (axSpA) is a type of inflammatory arthritis that primarily affects the entheses of the spine and/or sacroiliac joints. The cause of axSpA…
  • Abstract Number: 0570 • ACR Convergence 2024

    Prevalence of Comorbidities and Racial Disparities in Anterior Uveitis Risk Among Ankylosing Spondylitis Patients

    Halah Alfatlawi1, abdulmajeed alharbi2, eun seo kwak2, rawnag el sheikh2 and nezam altorok2, 1the university of toledo, Toledo, OH, 2the university of toledo, Toledo

    Background/Purpose: Ankylosing spondylitis (AS) is a chronic inflammatory condition primarily affecting the axial spine, commonly associated with extra-articular manifestations such as anterior uveitis (AU). Racial…
  • Abstract Number: 1120 • ACR Convergence 2024

    Long-Term Echocardiographic Findings in Idiopathic Recurrent Pericarditis Patients Treated with Anakinra

    Zeynep Toker Dincer1, Damla Raimoglu2, Erkin Yilmaz3, Ayten Dag1, Sejla Karup4, Melike Melikoglu1 and Serdal Ugurlu5, 1Istanbul University-Cerrahpasa, Cerrahpasa Medical Faculty, Department of Internal Medicine, Division of Rheumatology, Istanbul, Turkey, 2Istanbul University-Cerrahpasa, Cerrahpasa Medical Faculty, Department of Cardiology, Istanbul, Turkey, 3Istanbul University-Cerrahpasa, Cerrahpasa Medical Faculty, Istanbul, Turkey, 4Cerrahpasa Faculty of Medicine, Istanbul, Turkey, 5Istanbul University-Cerrahpasa, Istanbul, Turkey

    Background/Purpose: Idiopathic recurrent pericarditis (IRP) is characterized by recurrent pericarditis attacks, and autoinflammatory pattern has been highlighted due to similarities in both clinical features and…
  • Abstract Number: 1886 • ACR Convergence 2024

    Heterogeneity of VEXAS Syndrome: A Multicenter Case-series of 299 Cases from the French VEXAS Study Group (FRENVEX)

    Sophie Georgin-lavialle1, Benjamin Terrier2, Vincent Jachiet3, Rim Bourguiba4, jerome HAdjaj5, olivier Kosmider6 and Arsene Mekinian7, and French VEXAS study group, 1Sorbonne Université, Department of internal medicine, Tenon Hospital, Assistance Publique-Hôpitaux de Paris (AP-HP), Paris, France, 2Service de Médecine interne, Hôpital Cochin, AP-HP, Paris, Ile-de-France, France, 3Service de médecine interne, AP-HP, Hôpital Saint Antoine, Sorbonne Universite, Paris, France., Paris, France, 4Hopital des Forces de sécurité de l'interieur, La Marsa, Tunisia, 5Saint antoine APHP, Paris, France, 6Hopital Cochin, Paris, France, 7Saint Antoine University Hospital, Paris, France

    Background/Purpose: VEXAS syndrome is a monogenic somatic autoinflammatory syndrome associated with UBA1 mutations. Objective. To describe clinical characteristics, laboratory findings, main treatments and outcomes of…
  • Abstract Number: 2162 • ACR Convergence 2024

    Exploring Barriers to Rheumatoid Arthritis Treatment Changes: Insights into Patient Concerns

    Nicholas McCormick1, Jeffrey Curtis2, Amy Mudano3, Shilpa Venkatachalam4, Kelly Gavigan5, Fenglong xie6, Patrick Stewart7 and Kimberly Garza1, 1Auburn University, Auburn, AL, 2Illumination Health, Birmingham, AL, 3Illumination Health, Hoover, AL, 4Global Healthy Living Foundation, New York, NY, 5Global Healthy Living Foundation, Upper Nyack, NY, 6University of Alabama at Birmingham; Illumination Health, Birmingham, AL, 7Illumination Health, Vero Beach, AL

    Background/Purpose: People with rheumatoid arthritis (RA) often hesitate to adjust their treatment due to concerns about medication risks and benefits. This study investigates RA patients'…
  • « Previous Page
  • 1
  • …
  • 5
  • 6
  • 7
  • 8
  • 9
  • …
  • 26
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2026 American College of Rheumatology